The value of disease management - Part 2: Balancing cost and quality in the treatment of diabetes mellitus: An annotated bibliography of studies on the benefits of disease management services for the treatment of diabetes mellitus

Disease Management

Volumn 5, Issue 1, 2002, Pages 37-44

  Gillespie, Jeann Lee ^a  

^a National Pharmaceutical Council   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; BIGUANIDE DERIVATIVE; INSULIN; MEGLITINIDE; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE;

ARTICLE; DIABETES CONTROL; DIABETES MELLITUS; DIET THERAPY; ETHNIC DIFFERENCE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; INCIDENCE; INSULIN TREATMENT; MANAGED CARE ORGANIZATION; MEDICAID; MEDICAL LITERATURE; PATIENT EDUCATION; PHARMACY BENEFIT MANAGER; PHYSICAL ACTIVITY; QUALITY CONTROL; RACE DIFFERENCE; TREATMENT OUTCOME;

EID: 0036109670     PISSN: 1093507X     EISSN: None     Source Type: Journal    
DOI: 10.1089/109350702317377555     Document Type: Article

References (26)

1. Disease management: Definitions and exploration of issues
2. Live long and prosper with disease management
3. Industry partnerships: Disease management program flourish
4. Disease management: Compelling yet repelling
5. The myths and realities of disease management
6. The disease management boom
7. The impact of disease management on outcomes and cost of care: A study of low-income asthma patients
8. Diabetes mellitus
9. Report of the expert committee on the diagnosis and classification of diabetes mellitus
10. Standards of medical care for patients with diabetes mellitus. Position statement
11. Implications of the United Kingdom prospective diabetes study. Position statement
12. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
13. Implications of the diabetes control and complications trial. Position statement
14. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
15. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
16. Nutrition recommendations and principles for people with diabetes mellitus. Position statement
17. Diabetes mellitus and exercise. Position statement
18. The pharmacological treatment of hyperglycemia in NIDDM